SCHEMBL22479463

SCHEMBL22479463

CC(C)N1CCC2(CC1)C(=O)N(C)c1cc(Br)ccc12

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
OPRK1 P41145 7/20 0.44
OPRL1 P41146 7/20 0.44
OPRM1 P35372 6/20 0.44
OPRD1 P41143 3/20 0.44
CYP2D6 P10635 2/20 0.40
CYP1A2 P05177 1/20 0.36
CYP3A4 P08684 1/20 0.36
NFKB1 P19838 1/20 0.36
HTR2A P28223 1/20 0.36
HTR2C P28335 1/20 0.36
HTR2B P41595 1/20 0.36
HIF1A Q16665 1/20 0.36
EZH2 Q15910 1/20 0.36
BACE1 P56817 6/20 0.36
IP6K1 Q92551 1/20 0.36
MMP2 P08253 1/20 0.36
MMP9 P14780 1/20 0.36
LMNA P02545 1/20 0.34
MAPT P10636 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31559320 0.86 OPRK1 (0.45) OPRK1OPRL1OPRM1OPRD1BACE1
SCHEMBL31330332 0.83 OPRK1 (0.46) OPRK1OPRL1OPRM1OPRD1BACE1
SCHEMBL31559318 0.83 OPRK1 (0.46) OPRK1OPRL1OPRM1OPRD1BACE1
SCHEMBL22479372 0.82 OPRL1 (0.52) OPRK1OPRL1OPRM1OPRD1EZH2
SCHEMBL26021860 0.81 OPRL1 (0.56) OPRK1OPRL1OPRM1OPRD1CYP2D6
SCHEMBL22471605 0.80 OPRK1 (0.41) OPRK1OPRL1OPRM1OPRD1BACE1
SCHEMBL21904556 0.80 OPRK1 (0.41) OPRK1OPRL1OPRM1OPRD1EZH2
SCHEMBL30898612 0.80 OPRK1 (0.41) OPRK1OPRL1OPRM1OPRD1BACE1
SCHEMBL22479315 0.78 OPRL1 (0.48) OPRK1OPRL1OPRM1OPRD1BACE1
SCHEMBL22471405 0.77 BACE1 (0.40) OPRK1OPRL1OPRM1OPRD1CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3950682-B1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO LTD (CN) 2026-02-11 EP disclosed
US-12473298-B2 Amide compounds, preparation method therefor, and use thereof in the medical field SHANGHAI SYNERGY PHARMACEUTICAL SCIENCES CO., LTD. (CN) 2025-11-18 US disclosed
CN-113330008-B Preparation method of amide compound and application of amide compound in medicine field 上海华汇拓医药科技有限公司 2024-05-07 CN disclosed
EP-3950682-A1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD Shanghai Synergy Pharmaceutical Sciences Co., Ltd (CN) 2022-02-09 EP disclosed
WO-2020192652-A1 PREPARATION METHOD FOR AMIDE COMPOUNDS AND USE THEREOF IN MEDICAL FIELD 上海华汇拓医药科技有限公司 2020-10-01 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12473298-B2 Amide compounds, preparation method therefor, and use thereof in the medical field EZH2, IKZF2, EZH1 OPRK1 4724/4885OPRL1 4833/4885OPRM1 4637/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.